Evidence map›Paper›PMID 39609853›Full record

ArticleImmunity & ageing : I & A2024

Detection of HHV-5 HHV-6a HHV-6b and HHV-7 in the urine: potential use as a non-invasive diagnostic tool for immune profiling.

Shelia Govind, Pierre Olivier Lang, Alexander Bürkle, María Moreno-Villanueva, Claudio Franceschi, Miriam Capri, Jurgen Bernard, Birgit Weinberger, Beatrix Grubeck-Loebenstein, Simone Fiegl and 7 more

Abstract read
In one paragraph

Article in Immunity & ageing : I & A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shelia GovindMedicines and Healthcare Products Regulatory Agency (MHRA), South Mimms Laboratories, Potters Bar, UK.
Pierre Olivier LangGenolier Clinic, Genolier, Switzerland.
Alexander BürkleMolecular Toxicology Group, Department of Biology, University of Konstanz, Box 628, Konstanz, 78457, Germany.
María Moreno-VillanuevaMolecular Toxicology Group, Department of Biology, University of Konstanz, Box 628, Konstanz, 78457, Germany.
Claudio FranceschiInstitute of Biogerontology, Lobachevsky State University, Nizhny Novgorod, Russia.
Miriam CapriDepartment of Medical and Surgical Sciences, University of Bologna-Alma Mater Studiorum, Bologna, Italy.
Jurgen BernardBioTeSyS GmbH, Essliongen, Germany.
Birgit WeinbergerInstitute for Biomedical Aging Research, Universität Innsbruck, Innsbruck, Austria.
Beatrix Grubeck-LoebensteinInstitute for Biomedical Aging Research, Universität Innsbruck, Innsbruck, Austria.
Simone FieglUMIT TIROL, Innsbruck, Austria.
Efstathios S GonosNHRF, Institute of Biology, Athens, Greece.
Ewa SikoraPolish Academy of Sciences, Warsaw, Poland.
Eugène JansenCentre for Health Protection, National Institute for Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, Utrecht, The Netherlands.
Martijn E T DolléNational Institute for Public Health and the Environment, Utrecht, The Netherlands.
Tilman GruneDepartment of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, 14558, Germany.
Nicolle BreusingDepartment of Applied Nutritional Science/Dietetics, Institute of Nutritional Medicine, University of Hohenheim, 70599, Stuttgart, Germany.
Richard AspinallCentre for Intelligent Healthcare, Coventry University, Priory Street, COVENTRY, CV1 5FB, Conventry, UK. ac8908@coventry.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Decline in immune function with age has been studied extensively, but approaches to immune restoration have been hampered by the lack of simple methods of identifying individuals whose immune system is in decline. Our approach has been to identify individuals whose immune decline has led to a loss of control of common latent viral infections and their consequent reactivation. Viruses excreted in urine were detected and quantified and we believe this approach could provide a 'surrogate marker' for identifying immune compromised individuals. Here we report the detection of human herpes virus (HHV) 5, 6a, 6b and 7 in the urine of healthy individuals over a wide age range and their correlation with T cell receptor excision circle (TREC) data. The results did not show a clear correlation between TREC values and the detection of individual specific viruses or viral load values when measured singly. However, a correlation was found between low TREC values and the detection of several different human herpes viruses in the urine in males. We present evidence suggesting that for males, the detection of three or more different human herpes viruses in the urine could identify individuals with declining immune function as evidenced by their significantly lower TREC levels.

Indexed as

Human Herpes VirusT cell receptor excision circles

Identifiers

PMID39609853
PMCPMC11606101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.